Company intelligence / Profile preview
OMNIFARMA KIEV
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
Omnifarma is a Ukrainian pharmaceutical company founded in 2008 that specializes in the development, production, and marketing of innovative healthcare products and dietary supplements. The company is most recognized for its flagship product, White Coal (Bilyi Vuhillya), a high-efficiency silicon-based adsorbent used for detoxification and gastrointestinal health. Beyond adsorbents, Omnifarma maintains a diverse portfolio of products targeting hepatology, rheumatology, and general wellness. The company focuses on evidence-based formulations and has established a strong commercial presence in Ukraine and several international markets. Omnifarma operates its own manufacturing and R&D initiatives to ensure high-quality standards for its over-the-counter and supplemental offerings.
- Therapeutic areas
- Infectious DiseasesRheumatologyOtherGastroenterology
- Modalities
- Small moleculeNutraceutical
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on OMNIFARMA KIEV.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OMNIFARMA KIEV.